GENEVA, Jan. 5 -- KYOWA KIRIN CO., LTD. (1-9-2, OtemachiChiyoda-ku, Tokyo 1000004) filed a patent application (PCT/IB2025/056566) for "TIVOZANIB FOR TREATING POSTERIOR SEGMENT EYE DISEASES" on Jun 27, 2025. With publication no. WO/2026/003803, the details related to the patent application was published on Jan 02, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): HORITA, Shinya (c/o Kyowa Kirin, Inc.510 Carnegie Center, Suite 600Princeton, New Jersey 08540)
Abstract: Disclosed are methods of treating a human patient with a posterior segment eye disease, the method comprising topically administ...